As the obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a ...

The trial is funded in part by a $30m grant from the US Biomedical Advanced Research and Development Authority (BARDA).

Pfizer has announced data from the Phase III trial of TALZENNA plus XTANDI in patients with metastatic castration-resistant ...

Clario and PathAI partnered to offer an integrated solution for enhancing efficiency of gastrointestinal (GI) clinical trials ...